A landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes.
Mar 18 2024Deutsches Zentrum fuer Diabetesforschung DZD A landmark study by the German Diabetes Center , published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers employed an innovative algorithm to stratify people with type 2 diabetes using routine data and thus visualize the metabolic diversity of diabetes.
Algorithm for precision diabetes diagnosis The work presents a unique, tree-like representation of diabetes heterogeneity that was originally developed by researchers in Great Britain under the leadership of Ewan Pearson and has now been refined with data from the German Diabetes Study and the LURIC cohort. This innovative structure makes it possible to show different subtypes of type 2 diabetes in order to more clearly demonstrate how complex this disease is. Lead author Dr.
On the way to precision diabetology In recent years, countless results have been obtained at the DDZ for the purpose of subtyping diabetes mellitus. Continual refinement of these subtypes is now the goal for the precision diabetology of the future, says Prof. Dr. Michael Roden, director of the Clinic for Endocrinology and Diabetology at the University Hospital Düsseldorf and director of the DDZ.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers use algorithm to provide innovative insights into the heterogeneity of type 2 diabetesA landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers have employed an innovative algorithm to stratify people with type 2 diabetes using routine data and thus visualize the metabolic diversity of diabetes.
Read more »
Study shows glucose levels affect cognitive performance in people with type 1 diabetes differentlyA new study led by researchers at McLean Hospital (a member of Mass General Brigham) and Washington State University used advances in digital testing to demonstrate that naturally occurring glucose fluctuations impact cognitive function in people with type 1 diabetes (T1D).
Read more »
Weight loss caused by common diabetes drug tied to 'anti-hunger' molecule in studyAn 'anti-hunger' molecule produced after vigorous exercise is responsible for the moderate weight loss caused by the diabetes medication metformin, according to a new study in mice and humans. The molecule, lac-phe, was discovered by Stanford Medicine researchers in 2022.
Read more »
Nature vs nurture: Twin study sheds light on heritable brain activityThe way our brain processes different emotional and cognitive tasks may be underpinned by common factors, find scientists from UNSW and Neuroscience Research Australia (NeuRA).
Read more »
Spicing up diabetes management: Mediterranean diet's aromatic herbs lower blood sugarAromatic herbs and spices in the Mediterranean diet, especially black cumin, cinnamon, ginger, curcumin, and saffron, have been found to significantly improve glycemic profiles in patients with type 2 diabetes.
Read more »
Vitamin D₂ may help preserve honeymoon phase of type I diabetesA team of medical researchers and doctors affiliated with several universities and two hospitals in the U.S. reports that administration of vitamin D2 to patients newly diagnosed with diabetes type 1 can prolong the so-called honeymoon phase of the disease.
Read more »